Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Articles from our Partners at Consultant 360 October 2017

New Respiratory Disease Articles from our Partners at Consultant 360

Less-Frequent Therapy Better for COPD Lung Function, Quality of Life

http://bit.ly/2xVo3sy

Few studies have compared the effects of once-daily triple therapy with twice-daily dual therapy for COPD. In a recent study, researchers more thoroughly compared these treatments.

Lower Respiratory Infection Rates Have Decreased Globally, But Remain Burdensome

http://bit.ly/2xaGGto

In the Global Burden of Diseases, Injuries, and Risk Factors Study 2015, researchers aimed to estimate the global prevalence of lower respiratory infections and associated rates of mortality across all age groups.

Oral Corticosteroids Are Ineffective For Patients Without Asthma

http://bit.ly/2fEz86Q

Corticosteroids are increasingly being used as an alternative to antibiotics for the treatment of acute lower respiratory tract infections. In a recent study, researchers sought to determine if oral corticosteroids reduced symptom severity and duration of acute lower respiratory tract infections in adult patients without asthma.

Switching to Riociguat Could Benefit Certain PAH Patients

http://bit.ly/2xb1FaD

In a recent study, researchers sought to determine the feasibility and benefits of switching from treatment with PDE5i to riociguat in patients with PAH who fail to reach treatment goals while taking PDE5is.

Vascular Damage Similar With Use of E-Cigarettes and Conventional Cigarettes

http://bit.ly/2fEAMFD

Animal models have suggested possible vascular damage caused by e-cigarette use, but these findings were yet to be confirmed in humans. In a recent study, researchers examined the effects of nicotine exposure from e-cigarettes on the risk of arterial stiffness.